Yes. Addressing smoking—specifically, quitting rather than only cutting down—can help lower dementia risk.
The World Health Organization's 2026 guidelines identify tobacco as a modifiable risk factor and recommend stopping tobacco use. Risk reduction means lowering the likelihood of dementia, not guaranteeing prevention. The strongest evidence comes from large observational studies, which can show associations but cannot prove that quitting caused the lower risk.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How much difference might quitting make?
- Is cutting down enough?
- What are the evidence limits?
- Can quitting still matter later in life?
- How can someone act on this evidence?
How much difference might quitting make?
A 2026 Korean study followed 1,403,636 adults. Sustained quitters had progressively lower Alzheimer's disease risk than current smokers. Quitting for at least eight years was associated with a 42% lower hazard, meaning a lower relative rate during follow-up.
Quitting for two years or longer was associated with risk approaching that of never-smokers. People who had quit for less than two years still had excess risk compared with never-smokers, according to the study in Alzheimer's Research & Therapy. These findings suggest that maintaining cessation matters, but they do not establish an exact personal timeline.
Is cutting down enough?
The available evidence distinguishes quitting from smoking fewer cigarettes. In a 2023 Korean cohort of 789,532 current smokers, quitters had an 8% lower all-dementia risk than people who maintained their smoking intensity. The pattern was consistent for Alzheimer's and vascular dementia.
Participants who reduced their smoking by at least 20% had a 25% higher dementia risk than sustained smokers. Because the research was observational, it cannot show that reducing cigarettes caused that increase. Still, the JAMA Network Open study does not support treating reduction as equivalent to quitting for dementia-risk reduction.
What are the evidence limits?
These studies compared groups whose smoking behavior differed naturally; researchers did not randomly assign people to continue or quit. Other health or behavioral differences could therefore influence the results.
most participants in the 2023 cohort were Korean men, which limits how precisely its estimates transfer to other populations. The percentages are group-level comparisons, not predictions of whether one person will develop dementia. They support a risk-reduction decision, not a claim that quitting prevents every case.
Can quitting still matter later in life?
Evidence among older adults also points toward a benefit. A 2018 study followed 46,140 Korean men aged 60 or older for eight years.
Quitting for at least four years was associated with 14% lower overall dementia risk and 32% lower vascular-dementia risk than continued smoking. That finding supports considering cessation even later in life. However, it does not establish that every older adult will receive the same reduction or that the percentages apply equally across sexes and countries.
How can someone act on this evidence?
Make complete cessation the goal if lowering dementia risk is part of your motivation. Support and cessation medicines can improve the chances of quitting successfully. The World Health Organization's tobacco-cessation guidance recommends combining behavioral support with cessation medicines such as: Ask a clinician or tobacco-cessation service for a quit plan that combines behavioral support with an appropriate cessation medicine.
- Nicotine replacement therapy
- Varenicline
- Bupropion
- Cytisine
